Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Safe use of alteplase in a 10 months old infant with cardio-embolic stroke.

Rener-Primec Z, Švigelj V, Vesel S, Lovrič D, Škofljanec A.

Eur J Paediatr Neurol. 2013 Sep;17(5):522-5. doi: 10.1016/j.ejpn.2013.03.007. Epub 2013 Apr 19.

PMID:
23603009
3.

Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study.

Amlie-Lefond C, deVeber G, Chan AK, Benedict S, Bernard T, Carpenter J, Dowling MM, Fullerton H, Hovinga C, Kirton A, Lo W, Zamel K, Ichord R; International Pediatric Stroke Study.

Lancet Neurol. 2009 Jun;8(6):530-6. doi: 10.1016/S1474-4422(09)70106-1. Epub 2009 May 5.

PMID:
19423401
4.

SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.

Ciccone A, Valvassori L, Nichelatti M; SYNTHESIS Expansion investigators.

Int J Stroke. 2011 Jun;6(3):259-65. doi: 10.1111/j.1747-4949.2011.00587.x. Epub 2011 Mar 18.

PMID:
21557814
5.

Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.

Nakashima T, Toyoda K, Koga M, Matsuoka H, Nagatsuka K, Takada T, Naritomi H, Minematsu K.

Int J Stroke. 2009 Dec;4(6):425-31. doi: 10.1111/j.1747-4949.2009.00347.x.

PMID:
19930051
6.

A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.

Lang W, Stadler CH, Poljakovic Z, Fleet D; Lyse Study Group.

Int J Stroke. 2013 Feb;8(2):95-104. doi: 10.1111/j.1747-4949.2012.00901.x. Epub 2012 Sep 26.

PMID:
23009193
7.

Thrombolysis for acute ischaemic stroke.

Wardlaw JM, Zoppo G, Yamaguchi T, Berge E.

Cochrane Database Syst Rev. 2003;(3):CD000213. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000213.

PMID:
12917889
8.

Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.

Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K.

Stroke. 2011 Aug;42(8):2196-200. doi: 10.1161/STROKEAHA.111.614404. Epub 2011 Jun 30.

9.

Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients: the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study.

Chao AC, Hsu HY, Chung CP, Liu CH, Chen CH, Teng MM, Peng GS, Sheng WY, Hu HH; Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group.

Stroke. 2010 May;41(5):885-90. doi: 10.1161/STROKEAHA.109.575605. Epub 2010 Mar 11.

10.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

11.

Thrombolysis in young adults with ischemic stroke.

Putaala J, Metso TM, Metso AJ, Mäkelä E, Haapaniemi E, Salonen O, Kaste M, Tatlisumak T.

Stroke. 2009 Jun;40(6):2085-91. doi: 10.1161/STROKEAHA.108.541185. Epub 2009 Apr 16.

12.

Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.

Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators.

Stroke. 2009 Nov;40(11):3591-5. doi: 10.1161/STROKEAHA.109.562991. Epub 2009 Sep 17.

13.

Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset.

Otwell JL, Phillippe HM, Dixon KS.

Am J Health Syst Pharm. 2010 Jul 1;67(13):1070-4. doi: 10.2146/ajhp090501. Review.

PMID:
20554592
14.

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).

Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T; J-MARS Investigators.

Stroke. 2010 Sep;41(9):1984-9. doi: 10.1161/STROKEAHA.110.589606. Epub 2010 Jul 22.

15.

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB; ARTIS study group.

Trials. 2010 May 12;11:51. doi: 10.1186/1745-6215-11-51.

16.

Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke.

Qureshi AI, Ali Z, Suri MF, Kim SH, Shatla AA, Ringer AJ, Lopes DK, Guterman LR, Hopkins LN.

Neurosurgery. 2001 Jul;49(1):41-8; discussion 48-50.

PMID:
11440458
17.

Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?

Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS 3rd, Cacayorin ED, Grotta JC, Noser EA.

Stroke. 2007 Jan;38(1):80-4. Epub 2006 Nov 22.

18.

Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.

Jones ML, Holmes M.

Health Technol Assess. 2009 Sep;13 Suppl 2:15-21. doi: 10.3310/hta13suppl2/03. Review.

19.

[Thrombolysis by intravenous tissue plasminogen activator (t-PA)--current status and future direction].

Tanahashi N.

Brain Nerve. 2009 Jan;61(1):41-52. Review. Japanese.

PMID:
19177806
20.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
Items per page

Supplemental Content

Write to the Help Desk